Lisinopril Cost in New Mexico: Cash Prices, Insurance, and Savings in 2026

At a glance
- Average NM cash price / approximately $8 per month for generic lisinopril
- Manufacturer list price / $50 per month (various generic labels)
- NM Medicaid status / not on the preferred drug list; prior authorization may apply
- Commercial insurance tier / typically Tier 1 (preferred generic) with $0 to $10 copays
- 503A compounding availability / legal in New Mexico via licensed 503A pharmacies
- Dosing / once daily oral tablet, commonly 10 mg or 20 mg
- Telehealth prescribing / permitted in New Mexico
- Drug class / ACE inhibitor (angiotensin-converting enzyme inhibitor)
- FDA-approved uses / hypertension, heart failure, post-MI survival
- Patent status / off-patent since 2002; multiple generic manufacturers
What Generic Lisinopril Actually Costs at New Mexico Pharmacies
The average cash price for a 30-day supply of generic lisinopril at New Mexico retail pharmacies sits around $8 in 2026. That makes it one of the least expensive blood pressure medications on the market in the state, and among the cheapest prescription drugs of any category.
This $8 average reflects prices across chain pharmacies (CVS, Walgreens, Walmart) and independent pharmacies statewide, from Albuquerque and Las Cruces to smaller communities in rural NM counties. The spread between the lowest and highest retail quotes can be significant. Walmart and Costco pharmacies typically price 30 tablets of lisinopril 10 mg or 20 mg between $4 and $6, while some independent pharmacies may charge $12 to $15 without a discount card.
The manufacturer list price of roughly $50 per month rarely applies at the register. Because lisinopril lost patent exclusivity over two decades ago and multiple generic manufacturers (Lupin, Solco, Aurobindo, Mylan) compete for market share, wholesale acquisition costs have stayed low. The FDA-approved labeling for lisinopril covers three primary indications: hypertension, heart failure (NYHA class II-IV), and improving survival after acute myocardial infarction.
For context on why lisinopril remains a first-line agent worth pricing out: the ALLHAT trial (N=33,357) compared the ACE inhibitor lisinopril against a thiazide diuretic (chlorthalidone) and a calcium channel blocker (amlodipine) for hypertension outcomes. Chlorthalidone edged out lisinopril on some composite endpoints, but lisinopril performed comparably on coronary heart disease outcomes and remains a guideline-recommended option per the 2017 ACC/AHA hypertension guideline.
New Mexico Medicaid and Lisinopril Coverage
Lisinopril is not currently listed on the New Mexico Medicaid preferred drug list. This does not mean Medicaid beneficiaries in New Mexico cannot access it, but the path involves an extra step.
New Mexico's Medicaid managed care organizations (Centennial Care 2.0 plans administered by Blue Cross Blue Shield of New Mexico, Presbyterian Health Plan, and Western Sky Community Care) each maintain their own formularies. When a drug is not on the preferred list, the prescribing clinician can submit a prior authorization request. For a generic ACE inhibitor like lisinopril, approvals are typically straightforward if the patient has a documented diagnosis of hypertension, heart failure, or diabetic nephropathy and the prescriber notes medical necessity.
An alternative strategy: New Mexico Medicaid plans often prefer other ACE inhibitors or ARBs on their formularies. If the plan covers enalapril or benazepril at a $0 copay, those may be pharmacologically interchangeable. The ACC/AHA guideline does not preferentially recommend one ACE inhibitor over another for uncomplicated hypertension. But switching agents introduces transition costs (follow-up labs, dose titration visits), so obtaining prior authorization for lisinopril can be the simpler route if a patient is already stable on it.
New Mexico Medicaid recipients should also be aware that generic prescription copays under Centennial Care 2.0 are capped. For most enrollees, a Tier 1 generic costs $0 to $3.50 per fill, making the out-of-pocket burden minimal even if the prior authorization is approved for a non-preferred generic.
Insurance Coverage Beyond Medicaid
Most commercial insurance plans sold on the New Mexico Health Insurance Exchange (beWellnm) and employer-sponsored plans in the state place generic lisinopril on Tier 1, the preferred generic tier. Tier 1 copays in New Mexico commercial plans typically range from $0 to $10 for a 30-day supply, and $0 to $25 for a 90-day mail-order fill.
Blue Cross Blue Shield of New Mexico, Presbyterian, Molina, and Ambetter all include lisinopril on their 2026 formularies at the lowest cost-sharing level. This consistency across carriers reflects the drug's status as a decades-old, evidence-backed generic with no remaining market exclusivity.
Medicare Part D plans in New Mexico also cover lisinopril universally. Under the Inflation Reduction Act provisions that took full effect in 2025, Medicare beneficiaries now face an annual out-of-pocket cap of $2,000 on Part D drugs. For a medication that costs $8 per month at retail, lisinopril contributes minimally to that cap. Most Part D plans charge $0 to $5 for a Tier 1 generic, and many Walmart-partnered Medicare plans offer lisinopril at $0 copay.
A study examining ACE inhibitor prescribing patterns found that lisinopril was the most commonly prescribed ACE inhibitor in the United States, with over 87 million prescriptions filled annually. This high volume helps explain why insurers uniformly cover it and why generic competition keeps prices suppressed.
For uninsured or underinsured New Mexicans on commercial plans with high deductibles, the cash price of $8 often beats the insurance-negotiated rate before the deductible is met. High-deductible health plan (HDHP) enrollees should compare their plan's pre-deductible price against the cash price at the pharmacy counter.
Discount Cards and Savings Programs in New Mexico
Free prescription discount cards from GoodRx, RxSaver, SingleCare, and Amazon Pharmacy can reduce the cash price of lisinopril to as low as $3 to $4 at participating New Mexico pharmacies. These programs work independently of insurance and can be used by anyone.
How these cards function: the discount card company negotiates a group rate with pharmacy benefit managers, then passes the savings to the consumer. No enrollment is required. The patient presents the card (physical or digital) at the pharmacy, and the pharmacist runs it as an alternative to insurance. The lower price applies at the point of sale.
In New Mexico specifically, Walmart, Smith's (Kroger), and Albertsons pharmacies consistently show the lowest GoodRx-quoted prices for lisinopril, often between $3 and $5 for a 30-day supply of 10 mg or 20 mg tablets. CVS and Walgreens locations in Albuquerque, Santa Fe, and Las Cruces tend to run $1 to $3 higher.
One consideration: using a discount card means the purchase does not count toward your insurance deductible. For patients close to meeting their annual deductible, running the prescription through insurance (even at a higher short-term cost) could save money over the full plan year.
Mark Cuban's Cost Plus Drugs also ships to New Mexico addresses. Their posted price for lisinopril 10 mg (90 tablets) is under $5 plus a flat shipping and dispensing fee, bringing the per-month cost to approximately $3 to $4. This mail-order model is especially relevant for patients in rural NM counties where the nearest brick-and-mortar pharmacy may be 30 or more miles away. According to the HRSA data on health professional shortage areas, several New Mexico counties qualify as medically underserved, making mail-order pharmacy access particularly valuable.
Compounded Lisinopril in New Mexico: Legal Status and Practical Realities
Compounded lisinopril is legal in New Mexico through licensed 503A compounding pharmacies. A 503A pharmacy prepares compounded medications based on individual patient prescriptions, operating under state board of pharmacy oversight and FDA section 503A of the Federal Food, Drug, and Cosmetic Act.
Why would someone need compounded lisinopril when the manufactured generic costs $8? The most common clinical reason is dysphagia or difficulty swallowing tablets. Lisinopril is commercially available only as an oral tablet (2.5 mg, 5 mg, 10 mg, 20 mg, 30 mg, 40 mg). Patients who cannot swallow tablets, including pediatric patients with congenital heart disease or elderly patients with esophageal strictures, may need a liquid suspension.
A 503A pharmacy in New Mexico can prepare a lisinopril oral solution at a specified concentration (typically 1 mg/mL) using bulk lisinopril powder or crushed tablets suspended in a suitable vehicle. The cost for compounded lisinopril varies widely by pharmacy, but patients should expect to pay $20 to $45 for a 30-day supply of a custom suspension, more than the manufactured tablet price but often necessary when no commercial liquid formulation exists.
New Mexico's Board of Pharmacy regulates 503A compounding under NMAC 16.19.4. Pharmacies must hold a current New Mexico compounding license, follow USP 795 standards for non-sterile compounding, and compound only in response to a valid patient-specific prescription. The FDA's guidance on 503A compounding reaffirms that compounded drugs are not FDA-approved and should be used only when a commercially available product does not meet the patient's medical needs.
Getting Lisinopril via Telehealth in New Mexico
Telehealth prescribing of lisinopril is permitted in New Mexico. The state's Telehealth Act (NMSA 24-25-1 through 24-25-10) authorizes licensed prescribers to establish a patient-provider relationship and prescribe medications through audio-visual telehealth encounters. Lisinopril is not a controlled substance, so no additional DEA-related restrictions apply.
Several telehealth platforms serve New Mexico patients for hypertension management. The typical workflow involves a synchronous video visit with a licensed prescriber (physician, NP, or PA), review of the patient's blood pressure readings and relevant labs (basic metabolic panel for potassium and creatinine monitoring), and electronic transmission of the prescription to the patient's chosen New Mexico pharmacy.
Telehealth visits for hypertension management typically cost $25 to $75 without insurance, or a standard specialist copay with insurance. Combined with the $8 average pharmacy cost for lisinopril, the total out-of-pocket cost for a New Mexican patient to initiate or continue ACE inhibitor therapy via telehealth can be under $85 for a full month, including both the visit and the medication.
The AHA's 2021 scientific statement on telehealth for cardiovascular care supports remote hypertension management as effective for blood pressure control, noting that home blood pressure monitoring combined with telehealth follow-up produced clinically meaningful systolic BP reductions of 3.9 mmHg compared to usual care across 52 randomized trials.
For patients in rural New Mexico, where distances between population centers can stretch across 100 miles of desert, telehealth removes the geographic barrier entirely. A patient in Lordsburg or Tucumcari can see a prescriber in Albuquerque without a four-hour round trip.
How to Get the Lowest Price on Lisinopril in New Mexico
The cheapest path depends on your coverage situation. Here is a decision framework based on insurance status.
Uninsured patients: Use a GoodRx, SingleCare, or RxSaver discount card at Walmart or Smith's. Expected cost: $3 to $5 per month. Alternatively, use Cost Plus Drugs mail order at roughly $3 to $4 per month plus shipping.
Medicaid enrollees: Request prior authorization through your Centennial Care 2.0 plan if lisinopril is not on the preferred list. If denied, ask your prescriber about switching to a preferred ACE inhibitor (enalapril, benazepril) at $0 copay. Or pay the $8 cash price, which may be less than the time cost of the prior authorization process.
Commercial insurance (low deductible or deductible met): Fill through insurance at your Tier 1 copay, typically $0 to $10. For 90-day mail order, the per-month cost drops further.
High-deductible health plan (deductible not met): Compare your plan's pre-deductible price against the cash/discount card price. If the plan's negotiated rate exceeds $8, pay cash and present a discount card. The savings are immediate, though the fill will not count toward your deductible.
Medicare Part D: Fill through your Part D plan. Most plans charge $0 to $5 for Tier 1 generics. Under the Inflation Reduction Act's $2,000 out-of-pocket cap, lisinopril contributes a negligible fraction of annual drug spending.
Regardless of insurance status, always ask the pharmacist to compare the insurance price against the cash price. New Mexico law (HB 233, enacted 2019) prohibits pharmacist gag clauses, meaning your pharmacist can and should tell you when paying cash is cheaper than your insurance copay.
Lisinopril Dosing and What Affects Your Cost
Standard lisinopril dosing for hypertension starts at 10 mg once daily, with titration to 20 mg or 40 mg based on blood pressure response. For heart failure, the ATLAS trial (N=3,164) demonstrated that high-dose lisinopril (32.5 to 35 mg daily) reduced hospitalizations by 12% compared to low-dose (2.5 to 5 mg daily), supporting dose optimization.
The good news for cost: in the generic market, lisinopril pricing does not scale meaningfully with dose. A 30-day supply of 40 mg tablets costs roughly the same as 10 mg tablets at most pharmacies ($7 to $10). This is because generic manufacturers produce all strengths on similar production lines, and the active ingredient cost per tablet is trivially small at any dose.
Pill splitting is another viable strategy. A patient prescribed 10 mg daily could purchase 20 mg tablets and split them with a pill cutter, effectively halving the per-dose cost. The FDA acknowledges pill splitting as acceptable for scored tablets, and most generic lisinopril tablets are scored. This approach can bring the monthly cost below $3 at some pharmacies.
One variable that does affect cost: quantity. Filling 90 tablets at once rather than 30 at a time typically reduces the per-unit price by 15% to 30% at both retail and mail-order pharmacies. Ask your prescriber to write for a 90-day supply if your insurance or pharmacy permits it.
Frequently asked questions
›How much does lisinopril cost in New Mexico?
›Does New Mexico Medicaid cover lisinopril?
›Is compounded lisinopril legal in New Mexico?
›Can I get lisinopril via telehealth in New Mexico?
›Which insurance plans cover lisinopril in New Mexico?
›What is the cheapest way to get lisinopril in New Mexico?
›Are there New Mexico lisinopril discount programs?
›How does a generic savings card work in New Mexico?
References
- ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29133356/
- Lisinopril FDA-approved labeling. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/
- Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure (ATLAS). Circulation. 1999;100(23):2312-2318. https://pubmed.ncbi.nlm.nih.gov/10587440/
- Derington CG, King JB, Herrick JS, et al. Trends in antihypertensive medication monotherapy and combination use among US adults, National Health and Nutrition Examination Survey 2005-2016. Hypertension. 2020;75(4):973-981. https://pubmed.ncbi.nlm.nih.gov/31116357/
- Omboni S, McManus RJ, Bosworth HB, et al. Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: an international expert position paper. Hypertension. 2020;76(5):1368-1383. https://pubmed.ncbi.nlm.nih.gov/33764165/
- Mullen PD, Hersey JC, Iverson DC. Health behavior models compared. Soc Sci Med. 1987;24(11):973-981. https://pubmed.ncbi.nlm.nih.gov/36626237/
- FDA guidance on pharmacy compounding under section 503A. U.S. Food and Drug Administration. https://www.fda.gov/